Christopher Mutz - 12 Feb 2025 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ANIP	Common Stock	Award	$0	+24,808	+32%	$0.000000	101,585	12 Feb 2025	Direct	F1
transaction	ANIP	Common Stock	Award	$0	+16,538	+16%	$0.000000	118,123	12 Feb 2025	Direct	F2
transaction	ANIP	Common Stock	Tax liability	$86,789	-1,473	-1.2%	$58.92	116,650	14 Feb 2025	Direct	F3
transaction	ANIP	Common Stock	Tax liability	$69,761	-1,184	-1%	$58.92	115,466	15 Feb 2025	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 12, 2025.
F2	These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting.
F3	Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,697 shares of restricted stock, the grant of which was previously reported.
F4	Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,034 shares of restricted stock, the grant of which was previously reported.